Cytokines and other mediators in alopecia areata

Stamatis Gregoriou, Dafni Papafragkaki, George Kontochristopoulos, Eustathios Rallis, Dimitrios Kalogeromitros, Dimitris Rigopoulos, Stamatis Gregoriou, Dafni Papafragkaki, George Kontochristopoulos, Eustathios Rallis, Dimitrios Kalogeromitros, Dimitris Rigopoulos

Abstract

Alopecia areata, a disease of the hair follicles with multifactorial etiology and a strong component of autoimmune origin, has been extensively studied as far as the role of several cytokines is concerned. So far, IFN-gamma, interleukins, TNF-alpha, are cytokines that are well known to play a major role in the pathogenesis of the disease, while several studies have shown that many more pathways exist. Among them, MIG, IP-10, BAFF, HLA antigens, MIG, as well as stress hormones are implicated in disease onset and activity. Within the scope of this paper, the authors attempt to shed light upon the complexity of alopecia areata underlying mechanisms and indicate pathways that may suggest future treatments.

References

    1. Safavi KH, Muller SA, Suman VJ, Moshell AN, Melton LJ., III Incidence of alopecia areata in Olmsted County, Minnesota, 1975 through 1989. Mayo Clinic Proceedings. 1995;70(7):628–633.
    1. Muller SA, Winkelmann RK. Alopecia areata: an evaluation of 736 patients. Archives of Dermatology. 1963;88:290–297.
    1. Sato-Kawamura M, Aiba S, Tagami H. Strong expression of CD40, CD54 and HLA-DR antigen and lack of evidence for direct cellular cytotoxicity are unique immunohistopathological features in alopecia areata. Archives of Dermatological Research. 2003;294(12):536–543.
    1. Arca E, Muşabak U, Akar A, Erbil AH, Taştan HB. Interferon-gamma in alopecia areata. European Journal of Dermatology. 2004;14(1):33–36.
    1. Deeths MJ, Endrizzi BT, Irvin ML, Steiner LP, Ericson ME, Hordinsky MK. Phenotypic analysis of T-cells in extensive alopecia areata scalp suggests partial tolerance. Journal of Investigative Dermatology. 2006;126(2):366–373.
    1. Kuwano Y, Fujimoto M, Watanabe R, et al. Serum chemokine profiles in patients with alopecia areata. British Journal of Dermatology. 2007;157(3):466–473.
    1. Benoit S, Toksoy A, Goebeler M, Gilitzer R. Selective expression of chemokine induced by Interferon-γ in alopecia areata. Journal of Investigative Dermatology. 1994;102:p. 556.
    1. Hoffmann R, Wenzel E, Huth A, et al. Cytokine mRNA levels in alopecia areata before and after treatment with the contact allergen diphenylcyclopropenone. Journal of Investigative Dermatology. 1994;103(4):530–533.
    1. Groves RW, Williams IR, Sarkar S, Nakamura K, Kupper TS. Analysis of epidermal IL-1 family members in vivo using transgenic mouse models. Journal of Investigative Dermatology. 1994;102:p. 556.
    1. Hoffmann R. The potential role of cytokines and T cells in alopecia areata. Journal of Investigative Dermatology Symposium Proceedings. 1999;4(3):235–238.
    1. Tarlow JK, Clay FE, Cork MJ, et al. Severity of alopecia areata is associated with a polymorphism in the interleukin-1 receptor antagonist gene. Journal of Investigative Dermatology. 1994;103(3):387–390.
    1. Philpott MP, Sanders DA, Bowen J, Kealey T. Effects of interleukins, colony-stimulating factor and tumour necrosis factor on human hair follicle growth in vitro: a possible role for interleukin-1 and tumour necrosis factor-α in alopecia areata. British Journal of Dermatology. 1996;135(6):942–948.
    1. Ahini RT, di Giovine FS, McDonagh AJG. Interleukin 1 composite genotypes as determinants for subtypes of alopecia areata. Journal of Investigative Dermatology Symposium Proceedings. 1999;4(3):p. 53.
    1. Galbraith GMP, Palesch Y, Gore EA, Pandey JP. Contribution of interleukin 1β and KM loci to alopecia areata. Human Heredity. 1999;49(2):85–89.
    1. Pociot F, Mølvig J, Wogensen L, Worsaae H, Nerup J. A TaqI polymorphism in the human interleukin-1β (IL-1β) gene correlates with IL-1β secretion in vitro. European Journal of Clinical Investigation. 1992;22(6):396–402.
    1. Teraki Y, Imanishi K, Shiohara T. Cytokines in alopecia areata: contrasting cytokine profiles in localized form and extensive form (alopecia universalis) Acta Dermato-Venereologica. 1996;76(6):421–423.
    1. Bodemer C, Peuchmaur M, Fraitaig S, Chatenoud L, Brousse N, De Prost Y. Role of cytotoxic T cells in chronic alopecia areata. Journal of Investigative Dermatology. 2000;114(1):112–116.
    1. Hoffmann R, Wenzel E, Huth A, et al. Growth factor mRNA levels in alopecia areata before and after treatment with the contact allergen diphenylcyclopropenone. Acta Dermato-Venereologica. 1996;76(1):17–20.
    1. Ansel J, Perry P, Brown J, et al. Cytokine modulation of keratinocyte cytokines. Journal of Investigative Dermatology. 1990;94(6, supplement):101S–107S.
    1. Symington FW. Lymphotoxin, tumor necrosis factor, and gamma interferon are cytostatic for normal human keratinocytes. Journal of Investigative Dermatology. 1989;92(6):798–805.
    1. Kim HS, Cho DH, Kim HJ, Lee JY, Cho BK, Park HJ. Immunoreactivity of corticotropin-releasing hormone, adrenocorticotropic hormone and α-melanocyte-stimulating hormone in alopecia areata. Experimental Dermatology. 2006;15(7):515–522.
    1. Kuwano Y, Fujimoto M, Watanabe R, et al. Serum BAFF and APRIL levels in patients with alopecia areata. Journal of Dermatological Science. 2008;50(3):236–239.
    1. Mackay F, Schneider P, Rennert P, Browning J. BAFF and APRIL: a tutorial on B cell survival. Annual Review of Immunology. 2003;21:231–264.
    1. Mackay F, Leung H. The role of the BAFF/APRIL system on T cell function. Seminars in Immunology. 2006;18(5):284–289.
    1. Paus R, Ito N, Takigawa M, Ito T. The hair follicle and immune privilege. Journal of Investigative Dermatology Symposium Proceedings. 2003;8(2):188–194.
    1. Christoph T, Müller-Röver S, Audring H, et al. The human hair follicle immune system: cellular composition and immune privilege. British Journal of Dermatology. 2000;142(5):862–873.
    1. Gilhar A, Ullmann Y, Berkutzki T, Assy B, Kalish RS. Autoimmune hair loss (alopecia areata)transferred by T lymphocytes to human scalp explants on SCID mice. Journal of Clinical Investigation. 1998;101(1):62–67.
    1. McDonagh AJG, Snowden JA, Stierle C, Elliott K, Messenger AG. HLA and ICAM-1 expression in alopecia areata in vivo and in vitro: the role of cytokines. British Journal of Dermatology. 1993;129(3):250–256.
    1. Zöller M, McElwee KJ, Vitacolonna M, Hoffmann R. Apoptosis resistance in peripheral blood lymphocytes of alopecia areata patients. Journal of Autoimmunity. 2004;23(3):241–256.
    1. Bloom BR, Bennett B. Mechanism of a reaction in vitro associated with delayed-type hypersensitivity. Science. 1966;153(3731):80–82.
    1. Shimizu T, Mizue Y, Abe R, Watanabe H, Shimizu H. Increased macrophage migration inhibitory factor (MIF) in the sera of patients with extensive alopecia areata. Journal of Investigative Dermatology. 2002;118(3):555–557.
    1. Shimizu T, Hizawa N, Honda A, et al. Promoter region polymorphism of macrophage migration inhibitory factor is string risk factor for young onset of extensive alopecia areata. Genes and Immunity. 2005;6(4):285–289.
    1. Kobayashi S, Nishihira J, Watanabe S, Todo S. Prevention of lethal acute hepatic failure by antimacrophage migration inhibitory factor antibody in mice treated with bacille Calmette-Guerin and lipopolysaccharide. Hepatology. 1999;29(6):1752–1759.
    1. Zhang X, Yu M, Yu W, Weinberg J, Shapiro J, McElwee KJ. Development of alopecia areata is associated with higher central and peripheral hypothalamic-pituitary-adrenal tone in the skin graft induced C3H/HeJ mouse model. Journal of Investigative Dermatology. 2009;129(6):1527–1538.
    1. Gupta P, Freyschmidt-Paul P, Vitacolonna M, et al. A chronic contact eczema impedes migration of antigen-presenting cells in alopecia areata. Journal of Investigative Dermatology. 2006;126(7):1559–1573.
    1. Hoffmann R, Wenzel E, Huth A, et al. Cytokine mRNA levels in alopecia areata before and after treatment with the contact allergen diphenylcyclopropenone. Journal of Investigative Dermatology. 1994;103(4):530–533.
    1. Happle R, van der Steen P, Perret C. The Renbok phenomenon: an inverse Kobner reaction observed in alopecia areata. European Journal of Dermatology. 1991;1:228–230.
    1. Herbst V, Zöller M, Kissling S, Wenzel E, Stutz N, Freyschmidt-Paul P. Diphenylcyclopropenone treatment of alopecia areata induces apoptosis of perifollicular lymphocytes. European Journal of Dermatology. 2006;16(5):537–542.
    1. Pan Y, Rao NA. Alopecia areata during etanercept therapy. Ocular Immunology and Inflammation. 2009;17(2):127–129.
    1. Posten W, Swan J. Recurrence of alopecia areata in a patient receiving etanercept injections. Archives of Dermatology. 2005;141(6):759–760.
    1. Sfikakis PP, Iliopoulos A, Elezoglou A, Kittas C, Stratigos A. Psoriasis induced by anti-tumor necrosis factor therapy: a paradoxical adverse reaction. Arthritis and Rheumatism. 2005;52(8):2513–2518.

Source: PubMed

Sponzoři a spolupracovníci

Zdravotní podmínky

Drogové intervence

3
Předplatit